Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1107 posts found.

Scottish reforms proven to work says SMC

March 4, 2015
Sales and Marketing NHS, NICE, Onglyza, PACE, SMC, Scotland, anne lee, scottish

The chief pharma advisor for the Scottish Medicines Consortium Anne Lee says changes to its processes have contributed to improved …

News
Sovaldi image

Gilead frustrated despite final NICE Sovaldi nod

February 25, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, sofosbuvir, sovaldi

NICE has published final guidance confirming its approval of Gilead’s controversial blockbuster hepatitis C treatment Sovaldi – but Gilead and …

News
Avastin image

Doctors appeal to prescribe Avastin off-label

February 25, 2015
Sales and Marketing Lucentis, NHS, NICE, Novartis, Roche, bevacizumab, wet AMD

NHS Clinical Commissioners have called for the removal of barriers preventing CCGs from prescribing Roche’s Avastin to treat wet age-related …

News
Dementia image

UK government spends £300 million on dementia

February 23, 2015
Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research

UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …

News

NICE is ‘setting prices too high’ for NHS

February 19, 2015
Sales and Marketing ABPI, NHS, NICE, QALY, costs, health, pharma

The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …

News
Mark Baker image

NICE unveils guidelines to monitor antibiotic prescribing

February 18, 2015
Sales and Marketing AMR, Antibiotics, GPs, NHS, NICE, antimicrobials, baker

NICE are asking UK doctors to spy on their colleagues in order to help tackle the growing threat of antimicrobial …

News
Celgene image

Celgene’s blood cancer pill too expensive for NHS

February 13, 2015
Sales and Marketing Celgene, NHS, NICE, Pomalidomide, imnovid, myeloma

NICE has decided not to recommend Celgene’s Imnovid for treating patients with multiple myeloma – a cancer that affects white …

News
NHS image

New support guidelines for NHS whistleblowers

February 12, 2015
Medical Communications, Sales and Marketing CCG, Jeremy Hunt, NHS, comms, robert francis, whistleblowers

New guidelines to support NHS whistleblowers have been proposed by Sir Robert Francis QC – who led the inquiry into …

News
NHS image

NHS reform was ‘distracting and damaging’

February 6, 2015
Sales and Marketing CDF, Cameron, NHS, UK, coalition, healthcare, king's fund

Healthcare think tank The King’s Fund has said through a report that organisational changes to the NHS under the coalition …

News
Stephen Whitehead image

Stephen Whitehead: pharma has transformed

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, Stephen Whitehead, lgbt, pharma

According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …

Feature

Patients lack data confidence in NHS

January 30, 2015
Medical Communications, Sales and Marketing Astellas, NHS, care data, data, online, privacy

A recent pharma survey has found that a majority of Britons lack confidence in the NHS to keep their personal …

News
Soliris image

NICE approves world’s most expensive drug

January 28, 2015
Sales and Marketing Alexion, Dillon, NHS, NICE, aHUS, eculizumab, hst, soliris

The world’s most expensive drug has been approved in final guidance from NICE, making it the first drug to pass …

News

CDF chair: more treatment reviews to come

January 16, 2015
Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

News
Olysio image

Janssen privy to new pricing scheme and see NICE nod

January 16, 2015
Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir

Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …

News
Sovaldi image

NICE approves Sovaldi

January 16, 2015
Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026